[go: up one dir, main page]

WO2000058328A3 - Avermectinderivate - Google Patents

Avermectinderivate Download PDF

Info

Publication number
WO2000058328A3
WO2000058328A3 PCT/EP2000/002189 EP0002189W WO0058328A3 WO 2000058328 A3 WO2000058328 A3 WO 2000058328A3 EP 0002189 W EP0002189 W EP 0002189W WO 0058328 A3 WO0058328 A3 WO 0058328A3
Authority
WO
WIPO (PCT)
Prior art keywords
avermectin derivatives
relates
producing
agents
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/002189
Other languages
English (en)
French (fr)
Other versions
WO2000058328A2 (de
Inventor
Werner Hallenbach
Achim Harder
Andreas Turberg
Olaf Hansen
Samson-Himmelstjerna Georg Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to BR0009285-1A priority Critical patent/BR0009285A/pt
Priority to HK02107331.1A priority patent/HK1045698A1/zh
Priority to JP2000608028A priority patent/JP2002540214A/ja
Priority to AU43947/00A priority patent/AU4394700A/en
Priority to EP00925111A priority patent/EP1169328A2/de
Priority to CA002368465A priority patent/CA2368465A1/en
Publication of WO2000058328A2 publication Critical patent/WO2000058328A2/de
Publication of WO2000058328A3 publication Critical patent/WO2000058328A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Die Erfindung betrifft neue Avermectinderivate der Formel (I), in welcher R?1, R2, R3 und R4¿ die in der Beschreibung genannten Bedeutungen haben, mehrere Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Herstellung von Mitteln zur Bekämpfung von Ekto- und Endoparasiten am Tier.
PCT/EP2000/002189 1999-03-25 2000-03-13 Avermectinderivate Ceased WO2000058328A2 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BR0009285-1A BR0009285A (pt) 1999-03-25 2000-03-13 Derivados de avermectina
HK02107331.1A HK1045698A1 (zh) 1999-03-25 2000-03-13 阿維菌素衍生物
JP2000608028A JP2002540214A (ja) 1999-03-25 2000-03-13 アベルメクチン誘導体
AU43947/00A AU4394700A (en) 1999-03-25 2000-03-13 Avermectin derivatives
EP00925111A EP1169328A2 (de) 1999-03-25 2000-03-13 Avermectinderivate
CA002368465A CA2368465A1 (en) 1999-03-25 2000-03-13 Avermectin derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913534.7 1999-03-25
DE19913534A DE19913534A1 (de) 1999-03-25 1999-03-25 Avermectinderivate

Publications (2)

Publication Number Publication Date
WO2000058328A2 WO2000058328A2 (de) 2000-10-05
WO2000058328A3 true WO2000058328A3 (de) 2001-04-26

Family

ID=7902359

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/002189 Ceased WO2000058328A2 (de) 1999-03-25 2000-03-13 Avermectinderivate

Country Status (9)

Country Link
EP (1) EP1169328A2 (de)
JP (1) JP2002540214A (de)
CN (1) CN1345327A (de)
AU (1) AU4394700A (de)
BR (1) BR0009285A (de)
CA (1) CA2368465A1 (de)
DE (1) DE19913534A1 (de)
HK (1) HK1045698A1 (de)
WO (1) WO2000058328A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10112318A1 (de) * 2001-02-05 2002-08-14 Henkel Kgaa Konditioniermittel
CN102578113A (zh) * 2012-01-18 2012-07-18 华南理工大学 蔗糖酯与甲维盐复配微胶囊杀虫剂及其制备方法
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
CN103601776A (zh) * 2013-11-25 2014-02-26 京博农化科技股份有限公司 一种甲维盐中间体的制备方法
CN103833811A (zh) * 2014-03-25 2014-06-04 武汉大学 一种阿维菌素衍生物及其制备方法
CN109824745A (zh) * 2019-01-24 2019-05-31 南开大学 一种伊维菌素衍生物的合成及应用
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH669382A5 (en) * 1986-05-21 1989-03-15 Ciba Geigy Ag 13-0-substd. milbemycin derivs. - with insecticidal, acaricidal, nematocidal and anthelmintic activity, prepd. by etherification of 13-0 unsubstituted cpds
EP0335541A2 (de) * 1988-03-26 1989-10-04 Pfizer Limited Antiparasitäre Avermectin-Derivate
US5451511A (en) * 1985-07-27 1995-09-19 Pfizer Inc. Process for the preparation of antiparasitic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451511A (en) * 1985-07-27 1995-09-19 Pfizer Inc. Process for the preparation of antiparasitic agents
CH669382A5 (en) * 1986-05-21 1989-03-15 Ciba Geigy Ag 13-0-substd. milbemycin derivs. - with insecticidal, acaricidal, nematocidal and anthelmintic activity, prepd. by etherification of 13-0 unsubstituted cpds
EP0335541A2 (de) * 1988-03-26 1989-10-04 Pfizer Limited Antiparasitäre Avermectin-Derivate

Also Published As

Publication number Publication date
CN1345327A (zh) 2002-04-17
JP2002540214A (ja) 2002-11-26
EP1169328A2 (de) 2002-01-09
CA2368465A1 (en) 2000-10-05
BR0009285A (pt) 2002-01-22
WO2000058328A2 (de) 2000-10-05
HK1045698A1 (zh) 2002-12-06
AU4394700A (en) 2000-10-16
DE19913534A1 (de) 2000-10-05

Similar Documents

Publication Publication Date Title
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
WO2001090071A3 (de) Substituierte iminoazine als herbizide
WO1999038877A3 (en) 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
HK1038744A1 (zh) 用於治療炎性疾病的化合物
WO2002032912A3 (en) Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
WO1999064409A3 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE316083T1 (de) Adamantanderivate
PL348451A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
IL149154A0 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
WO2002048148A3 (en) Pyrazolopyridine derivatives
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
WO2003051274A3 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU4609701A (en) Colouring agent for keratin containing fibres
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
WO2000058328A3 (de) Avermectinderivate
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
WO2003015780A3 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
EP1121932A4 (de) Heilmittel für augenerkrankungen
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
SE9904128D0 (sv) Novel compounds
WO2000043375A3 (de) Substituierte arylheterocyclen

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00805507.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000925111

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2000 608028

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2368465

Country of ref document: CA

Ref document number: 2368465

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09937456

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000925111

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000925111

Country of ref document: EP